CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 105 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,989 | -99.8% | 258,687 | +43.3% | 0.36% | +345.0% |
| Q4 2021 | $2,944,000 | +27.8% | 180,500 | 0.0% | 0.08% | +53.8% |
| Q3 2021 | $2,303,000 | -9.7% | 180,500 | 0.0% | 0.05% | 0.0% |
| Q2 2021 | $2,549,000 | -9.1% | 180,500 | 0.0% | 0.05% | +4.0% |
| Q1 2021 | $2,805,000 | -2.0% | 180,500 | 0.0% | 0.05% | -18.0% |
| Q4 2020 | $2,863,000 | – | 180,500 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |